TVTX
USDTravere Therapeutics Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$32.600
Máximo
$34.605
Mínimo
$32.310
Volume
0.26M
Fundamentos da empresa
Capitalização de mercado
3.1B
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
2.25M
Bolsa de valores
NGM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Travere Therapeutics to Participate at Upcoming Investor Conferences
Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that company management will participate in the following upcoming investor conferences: Guggenheim's 2nd Annual Healthcare Innovation Conference Presenting
Piper Sandler Maintains Neutral on Travere Therapeutics, Raises Price Target to $35
Piper Sandler analyst Allison Bratzel maintains Travere Therapeutics with a Neutral and raises the price target from $26 to $35.
TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $40
TD Cowen analyst Tyler Van Buren maintains Travere Therapeutics with a Buy and raises the price target from $30 to $40.
Travere Therapeutics to Report Third Quarter 2025 Financial Results
Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced it will report third quarter 2025 financial results on Thursday, October 30, 2025, after the close of the U.S. financial markets. The Company will host a
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.